<DOC>
	<DOC>NCT01497535</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this trial is to compare the within-subject variability of insulin detemir to that of another basal insulin analogue, insulin glargine in healthy volunteers.</brief_summary>
	<brief_title>Within-subject Variability of Insulin Detemir in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Healthy Japanese men or women Holding a Japanese passport and Japaneseborn parents Considered generally healthy upon completion of medical history and physical examination as judged by the Investigator Body Mass Index (BMI) between 18 and 30 kg/m^2, incl. Fasting blood glucose maximum 6 mmol/L Clinically significant abnormal haematology or biochemistry screening tests, as judged by the Investigator Any serious systemic infectious disease that occurred during the four weeks prior to the first dose of the trial product, as judged by the Investigator Subject with history of alcohol or drug dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>